自体外周血干细胞移植解救治疗抗拒性非霍奇金淋巴瘤1例报告
摘要
抗拒性淋巴瘤的预后不良,大剂量化疗联合自体干细胞移植解救治疗是目前的热点之一,但其价值尚不清楚,本文综述了近年来临床研究道,并附1例我们的治疗结果。
出处
《现代肿瘤医学》
CAS
2009年第10期1963-1965,共3页
Journal of Modern Oncology
参考文献13
-
1Fernandez HF, Escalon MP, Pereira D, et al. Autotransplant conditioning regimens for aggressive lymphoma:are we on the right road [J] ? Bone Marrow Transplant,2007,40(6) :505 -513.
-
2Arranz R, Conde E, Grande C,et al. Dose -escalated CHOP and tailored intensification with IFE according to early response and followed by BEAM/autologous stem - cell transplantation in poor - risk aggressive B -cell lymphoma: a prospective study from the GEL - TAMO Study Group [ J ]. Eur J Haematol,2008,80 ( 3 ) :227 - 235.
-
3Rodriguez J, Conde E, Gutierrez A, et al. Frontline autologous stem cell transplantation in high - risk peripheral T - cell lymphoma: a prospective study from The Gel - Tamo Study Group [ J ]. Eur J Haematol,2007,79 ( 1 ) :32 - 38.
-
4Rodriguez J, Caballero MD, Gutierrez A, et al. High dose chemotherapy and autologous stem cell transplantation in patients with peripheral T - cell lymphoma not achieving complete response after induction chemotherapy. The GEL - TAMO experience [ J ]. Haematologica,2003,88(12) :1372 - 1377.
-
5Rodriguez J, Conde E, Gutierrez A, et al. Frontline autologous stem cell transplantation in high- risk peripheral T- cell lymphoma: a prospective study from The Gel - Tamo Study Group [ J ]. Eur J Haematol,2007,79( 1 ) :32 -38.
-
6Schutt P, Passon J, Ebeling P, et al. Ifosfamide, etoposide, cytarabine,and dexamethasone as salvage treatment followed by high - dose cyclophosphamide, melphalan, and etoposide with autologous peripheral blood stem cell transplantation for relapsed or refractory lymphomas[ J]. Eur J Haematol,2007,78 (2) :93 - 101.
-
7Robertson M J, Abonour R, Hromas R, et al. Augmented high - dose regimen of cyclophosphamide, carmustine, and etoposide with autologous hematopoietic stem cell transplantation for relapsed and re- fractory aggressive non - Hodgkin's lymphoma [ J]. Leuk Lymphoma,2005,46(10) : 1477 - 1487.
-
8Glossmann JP, Staak JO, Nogova L, et al. Autologous tandem transplantation in patients with primary progressive or relapsed/refractory lymphoma[ J ]. Ann Hematol,2005,84(8 ) :517 - 525.
-
9于燕霞,石远凯,何小慧,韩晓红,周生余,刘鹏,张长弓,杨建良,秦燕,杨晟,李博,冯奉仪.自体造血干细胞移植治疗复发难治非霍奇金淋巴瘤[J].中国肿瘤临床与康复,2007,14(3):230-233. 被引量：5
-
10Glossmann JP, Staak JO, Nogova L, et al. Autologous tandem transplantation in patients with primary progressive or relapsed/ refractory lymphoma [ J ]. Ann Hematol, 2005,84 ( 8 ) : 517 - 525.
二级参考文献10
-
1Gutierrez M,Chabner BA,Pearson D,et al.Role ofa doxorubicin-containing regimen in relapsed and resistant lymphomas:an 8-year follow-up study of EPOCH[J].J Clin Oncol,2000,18:3633-3642.
-
2Philip T,Guglielmi C,Hagenbeek A,et al.Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma[J].N Engl J Med,1995,333:1540-1545.
-
3Vese JM,Zhang MJ,Rowlings PA,et al.Autologous transplantation for diffuse aggressive non-Hodgkin's lymphoma in patients never achieving remission:a report from the Autologous Blood and Marrow Transplant Registry[J].J Clin Oncol,2001,19:406-413.
-
4Kewalramani T,Zelenetz AD,Hedrick EE,et al.High-dose chemoradiotherapy and autologoRs stem cell transplantation for patients with primary refractory aggressive non-Hodgkin lymphoma:an intention-to-treat analysis[J].Blood,2000,96:2399-2404.
-
5Tarella C,Di Nicola M,Caracciolo D,et al.High-dose Ara-C with autologous peripheral blood progenitor cell support induces a marked progenitor cell mobilization:an indication for patients at risk for low mobilization[J].Bone Marrow Transplant,2002,30:725-732.
-
6Kewalramani T,Zelenetz AD,Nimer SD.Rituximab and ICE as second-line therapy before autologous stem cell transplantation for relapsed or primary refractory diffuse large B-cell lymphoma blood[J].2004,103(10):3684-3688.
-
7Blay JY,Gomes F,Sebban C,et a;.The International Prognostic Index correlates to survival in patients with aggressive lymphoma in relapse:analysis of the PARMA trial[J].Blood,1998,92:3562-3568.
-
8Khouri IF,Saliba RM,Hosing C,et al.Concurrent administration of high-dose rituximab before and after autologous stem-cell tranaplantation for relapsed aggressive B-cell non-Hodgkin's lymphomas[J].J Clin Oncol,2005,23:2240-2247.
-
9Neumann F,Harmsen S,Martin S.Rituximab long-term maintenance therapy after autologous stem cell transplantation in patients with B.ceil non-Hodgkin's lymphoma[J].Ann Hematol,2006,85(8):530-534.
-
10石远凯,雷英衡,周生余,张红志,潘峰,吴世凯,罗克桓,韩晓红,周爱萍,吴冠青,冯奉仪.全身照射加足叶乙甙联合自体造血干细胞移植治疗非霍奇金淋巴瘤的疗效评价[J].中华医学杂志,1998,78(9):658-661. 被引量：11
共引文献4
-
1张红宾,刘林,王建渝,肖青,胡妮妮,唐晓琼,陈建斌,黄宗干.自体外周血干细胞移植治疗恶性淋巴瘤的临床分析[J].重庆医学,2009,38(14):1734-1735. 被引量：2
-
2杨昌云,陈少谊,陈志民.氟达拉滨联合化疗方案对复发性非霍奇金淋巴瘤的疗效研究[J].现代生物医学进展,2009,9(14):2685-2687. 被引量：3
-
3李虎生,张华.自体外周血造血干细胞移植治疗恶性淋巴瘤的研究进展[J].华夏医学,2010,23(3):321-325. 被引量：4
-
4陈顺珍.自体外周血造血干细胞移植治疗恶性淋巴瘤的护理[J].内科,2012,7(6):675-677. 被引量：2
-
1程刚,赵云博,李琳,衣林.自体外周血干细胞移植支持下大剂量化疗治疗小细胞肺癌[J].中华医学杂志,2000,80(8):601-601.
-
2申露.加强对多发性骨髓瘤病人的治疗可提高其存活率[J].中华医学信息导报,2003,18(18):10-10.
-
3马静秋,梁辉,董戴玉,严云,卞锦国,杨镜明.34例淋巴瘤骨髓浸润患者治疗与预后分析[J].上海第二医科大学学报,2004,24(5):343-344. 被引量：2
-
4韩文华.多西紫杉醇联合卡培他滨治疗晚期乳腺癌临床观察[J].中国实用医刊,2009,36(21):81-82.
-
5余洪金,方红明.多西他赛联合卡培他滨治疗蒽环类耐药晚期乳腺癌疗效分析[J].现代中西医结合杂志,2008,17(35):5481-5482.
-
6Canellos G P,罗克桓.晚期何杰金氏病的有效解救治疗[J].国外医学（肿瘤学分册）,1992,19(1):43-45. 被引量：2
-
7郎香花.泰索帝联合希罗达治疗21例晚期乳腺癌[J].肿瘤学杂志,2007,13(4):297-298.
-
8谭文勇,周立强.霍奇金淋巴瘤的综合治疗研究进展[J].国外医学（肿瘤学分册）,2003,30(4):315-317. 被引量：4
-
9孔北华,江森,李家福,沈柏均.自体骨髓移植联合大剂量化疗在妇科恶性肿瘤治疗中的应用[J].现代妇产科进展,1994,3(1):36-38.
-
10蔡洪川,邓立春,李胜元,翁锡定.大剂量化疗并放疗治疗中晚期食管癌效果观察[J].人民军医,1999,42(8):468-469.
